1 - 25 of 96 results for author:"Saya H." in Literature citations
Results Customize
› Repeat search in UniProtKB (45)
| Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision. Sato T., Chiba T., Ohno S., Sato C., Sugoh T., Miyashita K., Akatsuka H., Hozumi K., Okada Y., Iida Y. et al. J. Immunol. 189:4426-4436(2012) · Mapped (5) |
| Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Yae T., Tsuchihashi K., Ishimoto T., Motohara T., Yoshikawa M., Yoshida G.J., Wada T., Masuko T., Mogushi K., Tanaka H. et al. Nat Commun 3:883-883(2012) · Mapped (8) |
| LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression. Chiyoda T., Sugiyama N., Shimizu T., Naoe H., Kobayashi Y., Ishizawa J., Arima Y., Tsuda H., Ito M., Kaibuchi K. et al. J. Cell Biol. 197:625-641(2012) · Mapped (6) |
| Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion. Oikawa T., Oyama M., Kozuka-Hata H., Uehara S., Udagawa N., Saya H., Matsuo K. J. Cell Biol. 197:553-568(2012) · Mapped (14) |
| CD44s regulates the TGF-beta-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Mima K., Okabe H., Ishimoto T., Hayashi H., Nakagawa S., Kuroki H., Watanabe M., Beppu T., Tamada M., Nagano O. et al. Cancer Res. 72:3414-3423(2012) · Mapped (15) |
| Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells. Tamada M., Nagano O., Tateyama S., Ohmura M., Yae T., Ishimoto T., Sugihara E., Onishi N., Yamamoto T., Yanagawa H. et al. Cancer Res. 72:1438-1448(2012) · Mapped (6) |
| Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells. Masuko K., Okazaki S., Satoh M., Tanaka G., Ikeda T., Torii R., Ueda E., Nakano T., Danbayashi M., Tsuruoka T. et al. PLoS ONE 7:e29728-e29728(2012) · Mapped (6) |
| Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer. Arima Y., Hayashi H., Sasaki M., Hosonaga M., Goto T.M., Chiyoda T., Kuninaka S., Shibata T., Ohata H., Nakagama H. et al. J. Biol. Chem. 287:7896-7906(2012) · Mapped (18) |
| Fibroblast growth factor-2 is an important factor that maintains cellular immaturity and contributes to aggressiveness of osteosarcoma. Shimizu T., Ishikawa T., Iwai S., Ueki A., Sugihara E., Onishi N., Kuninaka S., Miyamoto T., Toyama Y., Ijiri H. et al. Mol. Cancer Res. 10:454-468(2012) · Mapped (9) |
| DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells. Takahashi A., Imai Y., Yamakoshi K., Kuninaka S., Ohtani N., Yoshimoto S., Hori S., Tachibana M., Anderton E., Takeuchi T. et al. Mol. Cell 45:123-131(2012) · Mapped (6) |
| Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells. Motohara T., Masuko S., Ishimoto T., Yae T., Onishi N., Muraguchi T., Hirao A., Matsuzaki Y., Tashiro H., Katabuchi H. et al. Carcinogenesis 32:1597-1606(2011) · Mapped (18) |
| Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells. Tabuse M., Ohta S., Ohashi Y., Fukaya R., Misawa A., Yoshida K., Kawase T., Saya H., Thirant C., Chneiweiss H. et al. Mol. Cancer 10:60-60(2011) · Mapped (1) |
| CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Ishimoto T., Nagano O., Yae T., Tamada M., Motohara T., Oshima H., Oshima M., Ikeda T., Asaba R., Yagi H. et al. Cancer Cell 19:387-400(2011) · Mapped (10) |
| Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy. Ohkawa M., Ohno Y., Masuko K., Takeuchi A., Suda K., Kubo A., Kawahara R., Okazaki S., Tanaka T., Saya H. et al. Biochem. Biophys. Res. Commun. 406:649-655(2011) · Mapped (4) |
| NKX2.2 suppresses self-renewal of glioma-initiating cells. Muraguchi T., Tanaka S., Yamada D., Tamase A., Nakada M., Nakamura H., Hoshii T., Ooshio T., Tadokoro Y., Naka K. et al. Cancer Res. 71:1135-1145(2011) · Mapped (20) |
| Identification of CD44 as a cell surface marker for Muller glia precursor cells. Shinoe T., Kuribayashi H., Saya H., Seiki M., Aburatani H., Watanabe S. J. Neurochem. 115:1633-1642(2010) · Mapped (16) |
| PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma. Loilome W., Juntana S., Namwat N., Bhudhisawasdi V., Puapairoj A., Sripa B., Miwa M., Saya H., Riggins G.J., Yongvanit P. Int. J. Cancer 129:34-44(2011) · Mapped (4) |
| c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis. Shimizu T., Ishikawa T., Sugihara E., Kuninaka S., Miyamoto T., Mabuchi Y., Matsuzaki Y., Tsunoda T., Miya F., Morioka H. et al. Oncogene 29:5687-5699(2010) · Mapped (3) |
| The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation. Naoe H., Araki K., Nagano O., Kobayashi Y., Ishizawa J., Chiyoda T., Shimizu T., Yamamura K., Sasaki Y., Saya H. et al. Mol. Cell. Biol. 30:3994-4005(2010) · Mapped (16) |
| PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties. Nagahama Y., Ueno M., Miyamoto S., Morii E., Minami T., Mochizuki N., Saya H., Takakura N. Cancer Res. 70:1215-1224(2010) · Mapped (5) |
| Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. Tajima K., Ohashi R., Sekido Y., Hida T., Nara T., Hashimoto M., Iwakami S., Minakata K., Yae T., Takahashi F. et al. Oncogene 29:1941-1951(2010) · Mapped (8) |
| Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Techasen A., Loilome W., Namwat N., Takahashi E., Sugihara E., Puapairoj A., Miwa M., Saya H., Yongvanit P. Cancer Sci. 101:658-665(2010) · Mapped (3) |
| CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis. Ishimoto T., Oshima H., Oshima M., Kai K., Torii R., Masuko T., Baba H., Saya H., Nagano O. Cancer Sci. 101:673-678(2010) · Mapped (13) |
| Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1. Arima Y., Hayashi H., Kamata K., Goto T.M., Sasaki M., Kuramochi A., Saya H. Exp. Dermatol. 19:e136-41(2010) · Mapped (10) |
| Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. Takahashi E., Nagano O., Ishimoto T., Yae T., Suzuki Y., Shinoda T., Nakamura S., Niwa S., Ikeda S., Koga H. et al. J. Biol. Chem. 285:4060-4073(2010) · Mapped (28) |